Aeglea BioTherapeutics Holdings, LLC — Form D/A
Aeglea BioTherapeutics Holdings, LLC of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2014-07-28. The offering totals $11.0M, of which $10.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-07-28
- Form: D/A
- Accession: 0001595365-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $10.7M
- Remaining: $293K
- Investors: 10
- Date of first sale: 2013-12-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209533
Issuer
- Name: Aeglea BioTherapeutics Holdings, LLC
- CIK: 0001595365
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 815-A BRAZOS STREET, AUSTIN, TX, 78701
- Phone: 650-387-5294
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| George Georgiou | Director | Edinburgh, X0 |
| David Lowe | Director | Walnut Creek, CA |
| Armen Shanafelt | Director | Austin, TX |
| HENRY SKINNER | Director | SAN DIEGO, CA |
| David Lowe | Executive Officer | Walnut Creek, CA |
| Charles York | Executive Officer | Austin, TX |
Other filings by this issuer (1)
More